Cargando…
Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate
Itaconate is derived from the tricarboxylic acid (TCA) cycle intermediate cis-aconitate and links innate immunity and metabolism. Its synthesis is altered in inflammation-related disorders and it therefore has potential as clinical biomarker. Mesaconate and citraconate are naturally occurring isomer...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146994/ https://www.ncbi.nlm.nih.gov/pubmed/33925995 http://dx.doi.org/10.3390/metabo11050270 |
_version_ | 1783697526852943872 |
---|---|
author | Winterhoff, Moritz Chen, Fangfang Sahini, Nishika Ebensen, Thomas Kuhn, Maike Kaever, Volkhard Bähre, Heike Pessler, Frank |
author_facet | Winterhoff, Moritz Chen, Fangfang Sahini, Nishika Ebensen, Thomas Kuhn, Maike Kaever, Volkhard Bähre, Heike Pessler, Frank |
author_sort | Winterhoff, Moritz |
collection | PubMed |
description | Itaconate is derived from the tricarboxylic acid (TCA) cycle intermediate cis-aconitate and links innate immunity and metabolism. Its synthesis is altered in inflammation-related disorders and it therefore has potential as clinical biomarker. Mesaconate and citraconate are naturally occurring isomers of itaconate that have been linked to metabolic disorders, but their functional relationships with itaconate are unknown. We aimed to establish a sensitive high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the quantification of itaconate, mesaconate, citraconate, the pro-drug 4-octyl-itaconate, and selected TCA intermediates. The assay was validated for itaconate, mesaconate, and citraconate for intra- and interday precision and accuracy, extended stability, recovery, freeze/thaw cycles, and carry-over. The lower limit of quantification was 0.098 µM for itaconate and mesaconate and 0.049 µM for citraconate in 50 µL samples. In spike-in experiments, itaconate remained stable in human plasma and whole blood for 24 and 8 h, respectively, whereas spiked-in citraconate and mesaconate concentrations changed during incubation. The type of anticoagulant in blood collection tubes affected measured levels of selected TCA intermediates. Human plasma may contain citraconate (0.4–0.6 µM, depending on the donor), but not itaconate or mesaconate, and lipopolysaccharide stimulation of whole blood induced only itaconate. Concentrations of the three isomers differed greatly among mouse organs: Itaconate and citraconate were most abundant in lymph nodes, mesaconate in kidneys, and only citraconate occurred in brain. This assay should prove useful to quantify itaconate isomers in biomarker and pharmacokinetic studies, while providing internal controls for their effects on metabolism by allowing quantification of TCA intermediates. |
format | Online Article Text |
id | pubmed-8146994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81469942021-05-26 Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate Winterhoff, Moritz Chen, Fangfang Sahini, Nishika Ebensen, Thomas Kuhn, Maike Kaever, Volkhard Bähre, Heike Pessler, Frank Metabolites Article Itaconate is derived from the tricarboxylic acid (TCA) cycle intermediate cis-aconitate and links innate immunity and metabolism. Its synthesis is altered in inflammation-related disorders and it therefore has potential as clinical biomarker. Mesaconate and citraconate are naturally occurring isomers of itaconate that have been linked to metabolic disorders, but their functional relationships with itaconate are unknown. We aimed to establish a sensitive high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the quantification of itaconate, mesaconate, citraconate, the pro-drug 4-octyl-itaconate, and selected TCA intermediates. The assay was validated for itaconate, mesaconate, and citraconate for intra- and interday precision and accuracy, extended stability, recovery, freeze/thaw cycles, and carry-over. The lower limit of quantification was 0.098 µM for itaconate and mesaconate and 0.049 µM for citraconate in 50 µL samples. In spike-in experiments, itaconate remained stable in human plasma and whole blood for 24 and 8 h, respectively, whereas spiked-in citraconate and mesaconate concentrations changed during incubation. The type of anticoagulant in blood collection tubes affected measured levels of selected TCA intermediates. Human plasma may contain citraconate (0.4–0.6 µM, depending on the donor), but not itaconate or mesaconate, and lipopolysaccharide stimulation of whole blood induced only itaconate. Concentrations of the three isomers differed greatly among mouse organs: Itaconate and citraconate were most abundant in lymph nodes, mesaconate in kidneys, and only citraconate occurred in brain. This assay should prove useful to quantify itaconate isomers in biomarker and pharmacokinetic studies, while providing internal controls for their effects on metabolism by allowing quantification of TCA intermediates. MDPI 2021-04-26 /pmc/articles/PMC8146994/ /pubmed/33925995 http://dx.doi.org/10.3390/metabo11050270 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Winterhoff, Moritz Chen, Fangfang Sahini, Nishika Ebensen, Thomas Kuhn, Maike Kaever, Volkhard Bähre, Heike Pessler, Frank Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate |
title | Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate |
title_full | Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate |
title_fullStr | Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate |
title_full_unstemmed | Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate |
title_short | Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate |
title_sort | establishment, validation, and initial application of a sensitive lc-ms/ms assay for quantification of the naturally occurring isomers itaconate, mesaconate, and citraconate |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146994/ https://www.ncbi.nlm.nih.gov/pubmed/33925995 http://dx.doi.org/10.3390/metabo11050270 |
work_keys_str_mv | AT winterhoffmoritz establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate AT chenfangfang establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate AT sahininishika establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate AT ebensenthomas establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate AT kuhnmaike establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate AT kaevervolkhard establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate AT bahreheike establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate AT pesslerfrank establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate |